These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34250730)

  • 41. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Aldinger JP; Dobyns T; Lam K; Han JK
    Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
    [No Abstract]   [Full Text] [Related]  

  • 42. Monoclonal Antibodies for the Treatment of Nasal Polyps.
    Willson TJ; Naclerio RM; Lee SE
    Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The development of a personalized approach in the treatment of chronic rhinosinusitis with nasal polyps].
    Moiseeva YP; Piskunov GZ
    Vestn Otorinolaringol; 2022; 87(3):40-45. PubMed ID: 35818944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) with monoclonal antibodies (biologics): S2k guideline of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), and the German College of General Practitioners and Family Physicians (DEGAM)].
    Pfaar O; Beule AG; Laudien M; Stuck BA;
    HNO; 2023 Apr; 71(4):256-263. PubMed ID: 36941387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatable traits in chronic rhinosinusitis with nasal polyps.
    Heffler E; Malvezzi L; Pirola F; Zięba N; Paoletti G; Mercante G; Spriano G; Canonica GW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):373-378. PubMed ID: 31135395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review.
    Chapurin N; Khan S; Gutierrez J; Soler ZM
    Am J Rhinol Allergy; 2023 Mar; 37(2):227-231. PubMed ID: 36848274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targetable pathogenic mechanisms in nasal polyposis.
    Schneider AL; Schleimer RP; Tan BK
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1220-1234. PubMed ID: 33660425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis.
    Lelegren MJ; Son SY; Han JK; Lam KK
    Immunotherapy; 2022 Jun; 14(8):655-662. PubMed ID: 35510314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biologics treatment of chronic rhinosinusitis with nasal polyps].
    Wang CS; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):193-199. PubMed ID: 36878496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allergic Fungal Rhinosinusitis: The Role and Expectations of Biologics.
    Luong AU; Chua A; Alim BM; Olsson P; Javer A
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3156-3162. PubMed ID: 36028212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EDS-FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps.
    Leopold DA; Elkayam D; Han JK; Soteres DF; Messina JC; Carothers JL; Sacks HJ; Mahmoud RA; Djupesland PG; Sindwani R
    Int Forum Allergy Rhinol; 2022 Jun; 12(6):893-895. PubMed ID: 35348302
    [No Abstract]   [Full Text] [Related]  

  • 52. Current and Future Treatments of Rhinitis and Sinusitis.
    Patel GB; Kern RC; Bernstein JA; Hae-Sim P; Peters AT
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1522-1531. PubMed ID: 32004747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Taste perception in patients with chronic rhinosinusitis with nasal polyps treated with oral glucocorticosteroid therapy].
    Dzaman K; Rapiejko P; Szczygielski K; Pleskacz W; Jurkiewicz D
    Otolaryngol Pol; 2009; 63(3):236-41. PubMed ID: 19886528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics.
    De Corso E; Pipolo C; Cantone E; Ottaviano G; Gallo S; Trimarchi M; Torretta S; Cavaliere C; Lucidi D; Seccia V; Settimi S; Canevari FRM; Pasquini E; La Mantia I; Garzaro M; Bellocchi G; De Benedetto M; Lombardo N; Macchi A; Malvezzi L; Motta G; Vicini C; Maselli A; Dell'Era V; Dragonetti A; Asprea F; Lupato V; Ghidini A; Masieri S; Mattavelli D; Salzano FA; Passali D; Galli J; Pagella F
    Acta Otorhinolaryngol Ital; 2023 Oct; 43(5):324-340. PubMed ID: 37224173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies.
    Kariyawasam HH
    Expert Rev Clin Immunol; 2019 Jan; 15(1):59-71. PubMed ID: 30370785
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of Short-Term Systemic Corticosteroid Therapy in Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Randomized Controlled Trials and Systematic Review.
    Zhang Y; Wang C; Huang Y; Lou H; Zhang L
    Am J Rhinol Allergy; 2019 Sep; 33(5):567-576. PubMed ID: 31132854
    [No Abstract]   [Full Text] [Related]  

  • 57. Biologics in Otolaryngology: Past, Present, and Future.
    Schmitt NC; Monfared A; Wise SK
    Otolaryngol Clin North Am; 2021 Aug; 54(4):675-687. PubMed ID: 34116845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.
    Klimek L; Jutel M; Bousquet J; Agache I; Akdis CA; Hox V; Gevaert P; Tomazic PV; Rondon C; Cingi C; Toppila-Salmi S; Karavelia A; Bozkurt B; Förster-Ruhrmann U; Becker S; Chaker AM; Wollenberg B; Mösges R; Huppertz T; Hagemann J; Bachert C; Fokkens W
    Allergy; 2021 Mar; 76(3):677-688. PubMed ID: 33075144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Out-of-pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population.
    Rathi VK; Scangas GA; Metson RB; Xiao R; Nshuti L; Dusetzina SB
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1295-1298. PubMed ID: 35029845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.